Given the association of this polymorphism with resistin expression levels and its potential impact on CRC growth, numerous research analyses have focused on the prevalence of the RETN C420G polymorphism in CRC patients, with controversial results [88-92]. Here, RETN is linked to colorectal carcinoma.